6-(Trifluoromethyl)-4-pyrimidinamine(CAS: 672-41-3)

6-(Trifluoromethyl)-4-pyrimidinamine (CAS: 672-41-3) falls under the scope of the REACH regulation in the European Union, which requires registration for substances above a certain tonnage. Additionally, it is classified and labeled according to the Globally Harmonized System of Classification and Labeling of Chemicals (GHS), which includes health hazards such as skin and eye irritation. In the United States, the Environmental Protection Agency (EPA) and Food and Drug Administration (FDA) may have specific requirements for handling and disposal depending on its intended use.

There are several alternatives to 6-(Trifluoromethyl)-4-pyrimidinamine (CAS: 672-41-3) in synthesis, including other pyrimidines and analogous compounds. For example, 5-(trifluoromethyl)pyrimidines and 4-(trifluoromethyl)pyrimidines can serve as functional analogs. In some cases, isomers or similar compounds such as 6-(difluoromethyl)-4-pyrimidinamine can be used as substitutes.

The market for 6-(Trifluoromethyl)-4-pyrimidinamine (CAS: 672-41-3) is driven by its use in pharmaceuticals, particularly as a precursor for drug synthesis. Research trends suggest increasing interest in its application in antiviral and anticancer therapies. Market demand is expected to grow as new applications are discovered, particularly in the development of novel drugs targeting specific molecular pathways.

Waste containing 6-(Trifluoromethyl)-4-pyrimidinamine (CAS: 672-41-3) should be collected in properly labeled containers and handled according to local regulations. Incineration is a common method for disposing of such waste, but professional waste disposal services should be used to ensure compliance with environmental protection standards. It is crucial to follow all safety precautions and ensure that waste is disposed of in a manner that does not pose a risk to human health or the environment.